Copyright Reports & Markets. All rights reserved.

Global Influenza Vaccine Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Influenza Vaccine Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Trivalent Influenza Vaccine
    • 1.3.3 Quadrivalent Influenza Vaccine
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Influenza Vaccine Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 6 Months to 3 Years
    • 1.4.3 > 3 Years
  • 1.5 Global Influenza Vaccine Market Size & Forecast
    • 1.5.1 Global Influenza Vaccine Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Influenza Vaccine Sales Quantity (2021-2032)
    • 1.5.3 Global Influenza Vaccine Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Sanofi
    • 2.1.1 Sanofi Details
    • 2.1.2 Sanofi Major Business
    • 2.1.3 Sanofi Influenza Vaccine Product and Services
    • 2.1.4 Sanofi Influenza Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Sanofi Recent Developments/Updates
  • 2.2 CSL
    • 2.2.1 CSL Details
    • 2.2.2 CSL Major Business
    • 2.2.3 CSL Influenza Vaccine Product and Services
    • 2.2.4 CSL Influenza Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 CSL Recent Developments/Updates
  • 2.3 GSK
    • 2.3.1 GSK Details
    • 2.3.2 GSK Major Business
    • 2.3.3 GSK Influenza Vaccine Product and Services
    • 2.3.4 GSK Influenza Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 GSK Recent Developments/Updates
  • 2.4 Viatris
    • 2.4.1 Viatris Details
    • 2.4.2 Viatris Major Business
    • 2.4.3 Viatris Influenza Vaccine Product and Services
    • 2.4.4 Viatris Influenza Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Viatris Recent Developments/Updates
  • 2.5 AstraZeneca
    • 2.5.1 AstraZeneca Details
    • 2.5.2 AstraZeneca Major Business
    • 2.5.3 AstraZeneca Influenza Vaccine Product and Services
    • 2.5.4 AstraZeneca Influenza Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 AstraZeneca Recent Developments/Updates
  • 2.6 Hualan Bio
    • 2.6.1 Hualan Bio Details
    • 2.6.2 Hualan Bio Major Business
    • 2.6.3 Hualan Bio Influenza Vaccine Product and Services
    • 2.6.4 Hualan Bio Influenza Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Hualan Bio Recent Developments/Updates
  • 2.7 Changchun Institute of Biological
    • 2.7.1 Changchun Institute of Biological Details
    • 2.7.2 Changchun Institute of Biological Major Business
    • 2.7.3 Changchun Institute of Biological Influenza Vaccine Product and Services
    • 2.7.4 Changchun Institute of Biological Influenza Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Changchun Institute of Biological Recent Developments/Updates
  • 2.8 Sinovac
    • 2.8.1 Sinovac Details
    • 2.8.2 Sinovac Major Business
    • 2.8.3 Sinovac Influenza Vaccine Product and Services
    • 2.8.4 Sinovac Influenza Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Sinovac Recent Developments/Updates
  • 2.9 BCHT
    • 2.9.1 BCHT Details
    • 2.9.2 BCHT Major Business
    • 2.9.3 BCHT Influenza Vaccine Product and Services
    • 2.9.4 BCHT Influenza Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 BCHT Recent Developments/Updates
  • 2.10 Jiangsu GDK
    • 2.10.1 Jiangsu GDK Details
    • 2.10.2 Jiangsu GDK Major Business
    • 2.10.3 Jiangsu GDK Influenza Vaccine Product and Services
    • 2.10.4 Jiangsu GDK Influenza Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Jiangsu GDK Recent Developments/Updates
  • 2.11 KM Biologics
    • 2.11.1 KM Biologics Details
    • 2.11.2 KM Biologics Major Business
    • 2.11.3 KM Biologics Influenza Vaccine Product and Services
    • 2.11.4 KM Biologics Influenza Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 KM Biologics Recent Developments/Updates

3 Competitive Environment: Influenza Vaccine by Manufacturer

  • 3.1 Global Influenza Vaccine Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Influenza Vaccine Revenue by Manufacturer (2021-2026)
  • 3.3 Global Influenza Vaccine Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Influenza Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Influenza Vaccine Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Influenza Vaccine Manufacturer Market Share in 2025
  • 3.5 Influenza Vaccine Market: Overall Company Footprint Analysis
    • 3.5.1 Influenza Vaccine Market: Region Footprint
    • 3.5.2 Influenza Vaccine Market: Company Product Type Footprint
    • 3.5.3 Influenza Vaccine Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Influenza Vaccine Market Size by Region
    • 4.1.1 Global Influenza Vaccine Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Influenza Vaccine Consumption Value by Region (2021-2032)
    • 4.1.3 Global Influenza Vaccine Average Price by Region (2021-2032)
  • 4.2 North America Influenza Vaccine Consumption Value (2021-2032)
  • 4.3 Europe Influenza Vaccine Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Influenza Vaccine Consumption Value (2021-2032)
  • 4.5 South America Influenza Vaccine Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Influenza Vaccine Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Influenza Vaccine Sales Quantity by Type (2021-2032)
  • 5.2 Global Influenza Vaccine Consumption Value by Type (2021-2032)
  • 5.3 Global Influenza Vaccine Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Influenza Vaccine Sales Quantity by Application (2021-2032)
  • 6.2 Global Influenza Vaccine Consumption Value by Application (2021-2032)
  • 6.3 Global Influenza Vaccine Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Influenza Vaccine Sales Quantity by Type (2021-2032)
  • 7.2 North America Influenza Vaccine Sales Quantity by Application (2021-2032)
  • 7.3 North America Influenza Vaccine Market Size by Country
    • 7.3.1 North America Influenza Vaccine Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Influenza Vaccine Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Influenza Vaccine Sales Quantity by Type (2021-2032)
  • 8.2 Europe Influenza Vaccine Sales Quantity by Application (2021-2032)
  • 8.3 Europe Influenza Vaccine Market Size by Country
    • 8.3.1 Europe Influenza Vaccine Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Influenza Vaccine Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Influenza Vaccine Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Influenza Vaccine Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Influenza Vaccine Market Size by Region
    • 9.3.1 Asia-Pacific Influenza Vaccine Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Influenza Vaccine Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Influenza Vaccine Sales Quantity by Type (2021-2032)
  • 10.2 South America Influenza Vaccine Sales Quantity by Application (2021-2032)
  • 10.3 South America Influenza Vaccine Market Size by Country
    • 10.3.1 South America Influenza Vaccine Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Influenza Vaccine Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Influenza Vaccine Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Influenza Vaccine Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Influenza Vaccine Market Size by Country
    • 11.3.1 Middle East & Africa Influenza Vaccine Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Influenza Vaccine Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Influenza Vaccine Market Drivers
  • 12.2 Influenza Vaccine Market Restraints
  • 12.3 Influenza Vaccine Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Influenza Vaccine and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Influenza Vaccine
  • 13.3 Influenza Vaccine Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Influenza Vaccine Typical Distributors
  • 14.3 Influenza Vaccine Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Influenza Vaccine market size was valued at US$ 10050 million in 2025 and is forecast to a readjusted size of US$ 14470 million by 2032 with a CAGR of 5.4% during review period.
    Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.
    Market Driver:The Influenza Vaccine market is driven by the rising global awareness of flu prevention and increasing government initiatives to promote vaccination programs. Seasonal influenza poses a significant public health burden, leading to hospitalizations and fatalities, particularly among high-risk populations such as the elderly, young children, and immunocompromised individuals. Governments and health organizations, including the WHO and CDC, actively support annual flu vaccination campaigns to reduce disease transmission. Additionally, advancements in vaccine technology, such as cell-based and recombinant influenza vaccines, are improving vaccine efficacy and production efficiency, further driving market growth.
    Market Challenge:Despite its importance, the Influenza Vaccine market faces challenges related to vaccine hesitancy, manufacturing constraints, and viral mutations. Public skepticism regarding vaccine safety and effectiveness, fueled by misinformation, hampers vaccination rates in some regions. Additionally, influenza viruses undergo frequent genetic mutations, requiring annual vaccine updates and posing challenges in predicting dominant strains. Manufacturing influenza vaccines is also time-sensitive, as traditional egg-based production methods have limitations in scalability and response speed during pandemics. These factors can impact supply chain stability and overall vaccine accessibility.
    Global key players of Pandemic Influenza Vaccine include Sanofi, CSL and GSK, etc. The top five players hold a share about 80%. North America is the largest market, has a share about 50%.
    This report is a detailed and comprehensive analysis for global Influenza Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Influenza Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (M Units), and average selling prices (US$/Unit), 2021-2032
    Global Influenza Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (M Units), and average selling prices (US$/Unit), 2021-2032
    Global Influenza Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (M Units), and average selling prices (US$/Unit), 2021-2032
    Global Influenza Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (M Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Influenza Vaccine
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Influenza Vaccine market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi, CSL, GSK, Viatris, AstraZeneca, Hualan Bio, Changchun Institute of Biological, Sinovac, BCHT, Jiangsu GDK, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Influenza Vaccine market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Trivalent Influenza Vaccine
    Quadrivalent Influenza Vaccine
    Market segment by Application
    6 Months to 3 Years
    > 3 Years
    Major players covered
    Sanofi
    CSL
    GSK
    Viatris
    AstraZeneca
    Hualan Bio
    Changchun Institute of Biological
    Sinovac
    BCHT
    Jiangsu GDK
    KM Biologics
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Influenza Vaccine product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Influenza Vaccine, with price, sales quantity, revenue, and global market share of Influenza Vaccine from 2021 to 2026.
    Chapter 3, the Influenza Vaccine competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Influenza Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Influenza Vaccine market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Influenza Vaccine.
    Chapter 14 and 15, to describe Influenza Vaccine sales channel, distributors, customers, research findings and conclusion.

    Buy now